RxDoctor Payments Data

Lisa Ducker, DO

Family Medicine · Langhorne, PANPI 1023125069

Payments from drug & device makers

$1,727in general payments, 2019–2025

Across 89 payments — averaging $19.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bausch Health US, LLC$370
  • Exact Sciences$246
  • Takeda Pharmaceuticals U.S.A., Inc.$200
  • AbbVie$174
  • GSK$150
  • Lilly USA, LLC$101
  • plus $487 from 14 others

What the payments were for

  • Food & beverage$1,727100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,727 in reported general payments places this provider in the 75th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$60,945
Medicare patients
108
Services billed
808

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide48$48,941
OzempicSemaglutide46$43,552
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$28,687
XareltoRivaroxaban18$23,295
JardianceEmpagliflozin24$21,095
EliquisApixaban23$17,786
Breo ElliptaFluticasone/Vilanterol17$11,441
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl75$8,588
SuboxoneBuprenorphine Hcl/Naloxone Hcl12$7,207
SteglatroErtugliflozin Pidolate11$3,795
Rosuvastatin Calcium158$2,524
Levothyroxine Sodium153$2,153
Losartan Potassium58$1,245
Gabapentin93$1,192
Metoprolol Succinate103$1,074

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$101$48,94148 claims
Novo NordiskOzempic$38$43,55246 claims
GSKTrelegy Ellipta, Breo Ellipta$150$40,12848 claims
PfizerEliquis$52$17,78623 claims
Indivior Inc.Suboxone$39$7,20712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Langhorne

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →